Judit Lazary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Judit Lazary has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Gyorgy Bagdy
Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary
6 shared publications - Xenia Gonda
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
3 shared publications Anita Benko
2 shared publications- Eszter Molnar
Semmelweis University
2 shared publications - Gabor Faludi
Department of Clinical and Theoretical Mental Health, Kutvolgyi Clinical Center, Semmelweis University, Budapest, Hungary
2 shared publications Gabriella Juhasz
2 shared publications
Latest Publications
- 1 December 2013
- Vol. 25 (4) , 379-88
The relationship between the big five personality dimensions and acute psychopathology: mediating and moderating effects of coping strategies.
Prior research suggests that the Big Five personality dimensions might be associated with coping strategies as well as acute psychopathology. The aim of the present study was to investigate direct and indirect associations between the Big Five personality traits, coping styles, and psychopathological variables. Subjects were 1140 adults from various institutions and regions in Hungary. A comprehensive test battery was administered including the Big Five Inventory (BFI), Psychological Immune System Inventory (PISI), and some subscales of the Brief Symptom Inventory (BSI). Several moderation-mediation analyses were conducted using the PROCESS tool in SPSS to test for influence paths. Coping and personality variables jointly accounted for 40% to 50% of variance in psychopathology outcome. Personality dimensions of Extraversion, Conscientiousness and Emotional Stability had strongest predictive values. Emotional Stability had a more direct and unmediated effect, whereas Extraversion and Conscientiousness effects were mediated by the Approach and Self-regulation coping systems. In comparison to personality, coping style was generally a stronger predictor. The findings of this study might add to better understanding of complex pathways leading from broad personality dimensions to coping strategies and psychological (mal)adjustment.
- 1 December 2013
- Vol. 25 (4) , 379-88
The relationship between the big five personality dimensions and acute psychopathology: mediating and moderating effects of coping strategies.
Prior research suggests that the Big Five personality dimensions might be associated with coping strategies as well as acute psychopathology. The aim of the present study was to investigate direct and indirect associations between the Big Five personality traits, coping styles, and psychopathological variables. Subjects were 1140 adults from various institutions and regions in Hungary. A comprehensive test battery was administered including the Big Five Inventory (BFI), Psychological Immune System Inventory (PISI), and some subscales of the Brief Symptom Inventory (BSI). Several moderation-mediation analyses were conducted using the PROCESS tool in SPSS to test for influence paths. Coping and personality variables jointly accounted for 40% to 50% of variance in psychopathology outcome. Personality dimensions of Extraversion, Conscientiousness and Emotional Stability had strongest predictive values. Emotional Stability had a more direct and unmediated effect, whereas Extraversion and Conscientiousness effects were mediated by the Approach and Self-regulation coping systems. In comparison to personality, coping style was generally a stronger predictor. The findings of this study might add to better understanding of complex pathways leading from broad personality dimensions to coping strategies and psychological (mal)adjustment.
- 1 August 2013
- Published by Karoli Gaspar Reformatus Egyetem in psychologia Hungarica Caroliensis
- Vol. 1 (1)
Klaszteralapú Big Five-személyiségprototípusok kapcsolata patológiás mutatókkal
- 1 August 2013
- Published by Karoli Gaspar Reformatus Egyetem in psychologia Hungarica Caroliensis
- Vol. 1 (1)
Klaszteralapú Big Five-személyiségprototípusok kapcsolata patológiás mutatókkal
- 12 September 2012
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 18 (32) , 4890-4896
Psychopharmacological Boundaries of Schizophrenia with Comorbid Cannabis Use Disorder: A Critical Review
Abstract: Although cannabis use disorder is strongly related to schizophrenia and treatment of patients with double diagnosis provides serious problem, specific pharmacological, molecular and therapeutical data on this subgroup are poorly available. In this paper we present a critical review on psychopharmacological boundaries of schizophrenia with concurrent cannabis use. The relevant data available in the literature suggest that a weaker compliance, poorer therapy response and higher sensitivity for extrapyramidal side effects are key features of schizophrenia and comorbid cannabis use disorder and represent a clinical challenge. Because of paucity of available research in the field there is not enough evidence to clearly depict the exact psychopharmacological profile of cannabis related schizophrenia. Further investigations are needed to assess phenotypic characteristics of this entity and to tailor effective treatment options accordingly.
- 12 September 2012
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 18 (32) , 4890-4896
Psychopharmacological Boundaries of Schizophrenia with Comorbid Cannabis Use Disorder: A Critical Review
Abstract: Although cannabis use disorder is strongly related to schizophrenia and treatment of patients with double diagnosis provides serious problem, specific pharmacological, molecular and therapeutical data on this subgroup are poorly available. In this paper we present a critical review on psychopharmacological boundaries of schizophrenia with concurrent cannabis use. The relevant data available in the literature suggest that a weaker compliance, poorer therapy response and higher sensitivity for extrapyramidal side effects are key features of schizophrenia and comorbid cannabis use disorder and represent a clinical challenge. Because of paucity of available research in the field there is not enough evidence to clearly depict the exact psychopharmacological profile of cannabis related schizophrenia. Further investigations are needed to assess phenotypic characteristics of this entity and to tailor effective treatment options accordingly.
- 1 January 2012
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 36 (1) , 155-160
Hopelessness, a potential endophenotpye for suicidal behavior, is influenced by TPH2 gene variants
- 1 January 2012
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 36 (1) , 155-160
Hopelessness, a potential endophenotpye for suicidal behavior, is influenced by TPH2 gene variants
- 1 December 2011
- Vol. 13 (4) , 185-92
Origins and perspectives of schizophrenia research.
Schizophrenia is a complex psychiatric disorder with a heterogeneous clinical phenotype. Ancient paradigms focused on clinical experiences and hypotheses mostly without validated measurements but in the modern neuroscientific era the trend has turned oppositely; although an expanding body of evidence is available in association with the neurobiological background of schizophrenia, it seems that development of phenotypic description has been missing from the focus. However, now it is clear that a relevant and sophisticated diagnostic system is also essential for the appropriate interpretation of comprehensive molecular studies. Besides a brief review of most important data on schizophrenia research, the authors call attention to a complex diagnostic system (Composite Diagnostic Evaluation, CODE) which can be a valuable clinical partner of currently accepted models of schizophrenia, such as the neurodevelopmental hypothesis.
- 1 December 2011
- Vol. 13 (4) , 185-92
Origins and perspectives of schizophrenia research.
Schizophrenia is a complex psychiatric disorder with a heterogeneous clinical phenotype. Ancient paradigms focused on clinical experiences and hypotheses mostly without validated measurements but in the modern neuroscientific era the trend has turned oppositely; although an expanding body of evidence is available in association with the neurobiological background of schizophrenia, it seems that development of phenotypic description has been missing from the focus. However, now it is clear that a relevant and sophisticated diagnostic system is also essential for the appropriate interpretation of comprehensive molecular studies. Besides a brief review of most important data on schizophrenia research, the authors call attention to a complex diagnostic system (Composite Diagnostic Evaluation, CODE) which can be a valuable clinical partner of currently accepted models of schizophrenia, such as the neurodevelopmental hypothesis.
- 1 March 2011
- Vol. 13 (1) , 7-13
Genetic and pharmacogenomic data on smoking: the bigger sample size, the less reliable phenotype? A critical review.
Increasing amount of genetic data on nicotine dependence (ND) is available in the literature, sometimes extremely large population size is reported but the study design is not always consequent. Phenotypic measures can vary from a simple 6-item self-rating scale to breath CO or serum cotinine level test but in genetic investigations this is not sophisticated; moreover the population stratification is also usually ignored. In contrast, possibly because of the strict traditions of pharmacological investigations, pharmacogenomic studies on smoking cessation therapy use more reliable phenotypic measures with high quality design consequently involving fewer participants. In spite of the heavy epidemiological data on smoking in Hungary, genetic background of heavy smoking is still not studied in this population. In this review we sum up the most important, replicated results but we also provide some critical remarks about the methodological shortcomings of these studies. Keeping in mind the value of large scale population ND association studies we would also like to emphasize that the clinical implementation of studies with larger samples but with weaker methodology and statistical analyses is limited. Similar to many other psychiatric disorders, ND is a multifactorial condition, therefore the measure of genetic effects requires a more complex study design.
- 1 March 2011
- Vol. 13 (1) , 7-13
Genetic and pharmacogenomic data on smoking: the bigger sample size, the less reliable phenotype? A critical review.
Increasing amount of genetic data on nicotine dependence (ND) is available in the literature, sometimes extremely large population size is reported but the study design is not always consequent. Phenotypic measures can vary from a simple 6-item self-rating scale to breath CO or serum cotinine level test but in genetic investigations this is not sophisticated; moreover the population stratification is also usually ignored. In contrast, possibly because of the strict traditions of pharmacological investigations, pharmacogenomic studies on smoking cessation therapy use more reliable phenotypic measures with high quality design consequently involving fewer participants. In spite of the heavy epidemiological data on smoking in Hungary, genetic background of heavy smoking is still not studied in this population. In this review we sum up the most important, replicated results but we also provide some critical remarks about the methodological shortcomings of these studies. Keeping in mind the value of large scale population ND association studies we would also like to emphasize that the clinical implementation of studies with larger samples but with weaker methodology and statistical analyses is limited. Similar to many other psychiatric disorders, ND is a multifactorial condition, therefore the measure of genetic effects requires a more complex study design.
- 15 January 2011
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (1) , 212-217
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
- 15 January 2011
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (1) , 212-217
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
- 1 January 2011
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 21 (1) , 63-70
Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality
- 1 January 2011
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 21 (1) , 63-70
Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality
- 1 June 2010
- Vol. 12 (2) , 347-54
Serotonin transporter gene and negative life change events are associated with depressive phenotype.
Although heritability of affective disorders is well accepted, several questions are still unsolved. The phenotype associated with the disorder is still uncertain, e.g., different disorders of the affective spectrum could be observed in the family of the patient. Furthermore, genetic studies failed to provide exact explanation for these questions either. We reported first that the role of the promoter region variant (5-HTTLPR) is not exclusive, and the middle region (tagged by the SNP rs140700) of the gene has also a significant role in the G x E model. Furthermore, we discovered a significant Gene x Gene x Environment interaction between 5-HTTLPR, rs140700 and threatening life events. Haplotype analyses of the serotonin transporter gene suggested that the majority of the S allele carriers for 5-HTTLPR with multiple threatening life events expressed high depression score, however, a subgroup with much lower depression score was also identified. In another study, interaction of 5-HTTLPR with the cannabinoid receptor 1 gene promoter was significantly associated with anxious phenotype. These results suggest that extremely high or low synaptic serotonin concentration could be associated with a high anxiety score. These findings call attention to the serotonergic dysfunction in the vulnerability for affective disorders.
- 1 June 2010
- Vol. 12 (2) , 347-54
Serotonin transporter gene and negative life change events are associated with depressive phenotype.
Although heritability of affective disorders is well accepted, several questions are still unsolved. The phenotype associated with the disorder is still uncertain, e.g., different disorders of the affective spectrum could be observed in the family of the patient. Furthermore, genetic studies failed to provide exact explanation for these questions either. We reported first that the role of the promoter region variant (5-HTTLPR) is not exclusive, and the middle region (tagged by the SNP rs140700) of the gene has also a significant role in the G x E model. Furthermore, we discovered a significant Gene x Gene x Environment interaction between 5-HTTLPR, rs140700 and threatening life events. Haplotype analyses of the serotonin transporter gene suggested that the majority of the S allele carriers for 5-HTTLPR with multiple threatening life events expressed high depression score, however, a subgroup with much lower depression score was also identified. In another study, interaction of 5-HTTLPR with the cannabinoid receptor 1 gene promoter was significantly associated with anxious phenotype. These results suggest that extremely high or low synaptic serotonin concentration could be associated with a high anxiety score. These findings call attention to the serotonergic dysfunction in the vulnerability for affective disorders.
- 30 July 2009
- Published by Elsevier in Psychiatry Research
- Vol. 168 (2) , 145-152
Association of depressive phenotype with affective family history is mediated by affective temperaments
- 30 July 2009
- Published by Elsevier in Psychiatry Research
- Vol. 168 (2) , 145-152
Association of depressive phenotype with affective family history is mediated by affective temperaments